Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial - Atreya, Raja; Peyrin-Biroulet, Laurent; Klymenko, Andrii; Augustyn, Monica; Bakulin, Igor; Slankamenac, Dusan; Miheller, Pal; Gasbarrini, Antonio; Hebuterne, Xavier; Arnesson, Karin; Knittel, Thomas; Kowalski, Jan; et al. (AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020)
CRIS-Team WoS Importer:2021-02-12